August 31 is International Overdose Awareness Day. The risk that gets discussed least is the one closest to home: the hours after someone already in treatment uses again, when the body no longer handles what it used to.
Between Lawrenceville and Norcross, the corridor along I-85 is full of households doing quiet work that never comes up at the office. A son home from a 30-day program downstate. A wife three weeks into an evening outpatient schedule. A father sober since March who has not told anyone how close last Friday came. Most of what gets said publicly on August 31 is about the people who did not make it. What matters more on an ordinary Tuesday in Gwinnett County is which moments actually carry the risk, and why so many of them fall inside treatment instead of before it.
Peachtree Recovery Solutions runs outpatient addiction treatment in Norcross, which means everyone in our groups goes home at the end of the day. That is the whole design of the level of care, and it is also the honest exposure inside it. A person tries out something new in the exact conditions that produced the problem, and some of those days do not go well. What happens in the hours afterward decides more than anything that came before.
None of that is a character question. What makes a return to use dangerous is physical, measurable, and largely preventable once the people around it know what they are looking at.
Returning to Use During Treatment Happens More Often Than Anyone Says Out Loud
If this has already happened in your house, or to you, start here: you have not landed on something rare. A recurrence of symptoms, the clinical term for what most people call a relapse, is common enough that the National Institute on Drug Abuse compares the rates after substance use treatment to the rates seen in high blood pressure and asthma. Nobody calls it a moral failure when a blood pressure regimen stops holding. The same logic applies here, and NIDA treats a recurrence as a signal to resume, modify, or change treatment.
That exposure is built in on purpose. Someone in intensive outpatient spends nine hours a week in group and the other 159 in the same apartment, the same drive up I-85, the same phone with the same numbers still in it. Skills that only function inside a locked building are not skills yet. But the distance between a hard Thursday and a bad hour is short, and it is better to plan around that than to hope past it.
Then there is the physical part. Tolerance, meaning the amount of a substance a body has adjusted to handling, drops off quickly once the substance stops. NIDA states it directly: a person who uses as much as they did before quitting can easily overdose, because the body is no longer adapted to that level of exposure. The dose that was routine in June can stop someone’s breathing in September. The current supply narrows that margin further, because fentanyl turns up in pills and powders sold as something else, and it is potent enough that small differences in a single dose matter.
Why Hiding It From Your Treatment Team Is the Dangerous Part
The instinct after a recurrence is almost always silence. People run the math fast. The group will hear about it. The family gets crushed a second time. The job might follow. The whole thing becomes proof to somebody that it was never going to work anyway. That calculation makes complete sense, and it is also where the actual danger enters, because it pushes the next use behind a closed door.
Being alone is the variable that turns an overdose into a fatal one. Naloxone only works when another person is there to give it, and someone whose breathing has slowed cannot administer it to themselves or dial a phone. A locked bedroom after several weeks of reduced tolerance removes the only safeguard that reliably works.
Georgia law is built around exactly this hesitation. The state’s Medical Amnesty Law gives limited immunity to anyone seeking medical help for themselves or another person during an overdose, covering possession of certain drugs and paraphernalia, some probation and parole violations, and underage alcohol possession, along with civil and criminal immunity for possessing and administering naloxone. Fear of a possession charge should never be the reason a 911 call does not get made in a Norcross apartment in the middle of the night.
What Happens After Someone Tells Us
Telling a clinical team is a different conversation than telling a family, and it helps to know that in advance. Clinically, the information is diagnostic. It answers a specific question about whether the current level of care still matches what the person in front of us needs, and that question has an answer.
The American Society of Addiction Medicine criteria, the framework treatment programs use to decide how intensive care should be, are written to be reassessed rather than set once. Someone attending three days a week who has used twice in a month is reporting, in the most reliable way available, that three days is not carrying the load right now. Moving up to partial hospitalization five days a week adjusts the dose of structure, the same way a physician raises a medication that is not holding a number where it needs to be.
The Questions a Clinical Team Works Through
- What was used, and how much: Opioids, alcohol, benzodiazepines, and stimulants each carry a different immediate risk, and more than one substance at a time changes the plan again.
- Whether withdrawal is now medically risky: Heavy drinking and benzodiazepine use that resumed and then stopped again can bring seizures. That situation calls for medically supervised detox before outpatient work continues.
- Whether the level of care still fits: More days, more structure, or a short stay in a residential setting before stepping back down.
- Whether medication should start or change: A first conversation about medication, or an adjustment to a dose that has stopped covering cravings.
- What happened in the hours before: The specific sequence gets worked in relapse prevention therapy, because a craving that seemed to come from nowhere usually has a traceable path behind it.
- Who else needs to know, and how: Sometimes a household needs the information to keep someone safe, and how it gets shared matters as much as whether it does.
Medically supervised withdrawal sits at its own level of care, ahead of outpatient rather than beside it. Peachtree Detox, part of the same Evoraa network, handles that piece from Fayetteville, and picking a PHP or IOP schedule back up in Norcross is the usual next move once the medical side is settled. Nobody has to argue their way back into a program. The only live question is how much support the next stretch takes.
Naloxone Belongs Where People Sleep
Every household with someone in early recovery from opioids should keep naloxone in it. Having it on hand says nothing about how much you believe in the person. It says you have read the same research the clinical team has, and NIDA is explicit that families should keep it nearby, ask the person to carry it, and make sure friends know where it is.
Naloxone reverses an opioid overdose by displacing opioids from the receptors they are sitting on and restoring breathing. NIDA is equally specific about the limits. It works in the body for only 30 to 90 minutes, many opioids last longer than that, and a person can slide back into overdose once it wears off, which is why 911 gets called every single time. Potent opioids can require more than one dose. It does nothing at all to a person who has no opioids in their system, and it will not reverse a cocaine or methamphetamine overdose.
It also brings on withdrawal within minutes in someone physically dependent: sweating, vomiting, a racing heart, tremors, a headache that arrives fast. People wake up sick and occasionally furious about it. NIDA’s own framing is worth saying out loud in advance so nobody freezes at the wrong moment. The risk of dying in an opioid overdose is worse than the risk of a rough reaction to naloxone.
Getting it in Georgia is straightforward. Naloxone is sold over the counter at most major pharmacies, including the ones along Jimmy Carter Boulevard and Peachtree Parkway, the state maintains a prescription standing order, and the Department of Public Health lists organizations distributing it free. Two boxes is a sensible number for a household: one where the person sleeps, one wherever people actually gather. In our sober apartments, roommates knowing where it is kept works the same way as knowing where the fire extinguisher is. Nobody expects to need it, and the knowing is the point.
How Medication Changes the Odds
Of everything in this conversation, medication moves the number the most, and it is still the piece argued about at kitchen tables from Duluth to Sugarloaf Parkway. SAMHSA’s position is short and worth quoting to a skeptical relative: the medications used for opioid and alcohol use disorder are evidence-based treatments, and they do not simply substitute one drug for another.
Medication for opioid and alcohol use disorder at Peachtree Recovery Solutions includes buprenorphine, prescribed as Suboxone or as the once-monthly Sublocade injection, and naltrexone, taken as a daily tablet or given as the monthly Vivitrol shot. Where overdose risk is concerned, what they share is that they close the gap a craving used to fill. Somebody whose withdrawal is controlled and whose cravings have gone quiet is not sitting in a parking lot at nine at night making a decision under physical pressure.
Two details rarely make it into the brochure. The first is that a buprenorphine dose set too low leaves cravings running underneath a program that looks fine from the outside, which is worth catching early rather than reading as personal weakness. The second is that any stretch without opioids lowers tolerance, including the stretch spent on a medication that blocks them, so stopping abruptly reopens the window treatment had closed. SAMHSA is direct that these medications are safe for long-term use, from months to a lifetime, and that stopping is a decision to make with a prescriber rather than during a bad week. Which medication makes sense, or whether one belongs in the plan at all, gets worked out person by person with our medical team, and any other controlled prescription goes through the same review.
Making the Plan Before Anyone Needs It
The most useful conversation a family can have is the dull one, held on a good day when nothing is wrong. Where the naloxone is kept. Who gets called first. What everyone agrees to do if somebody comes home and something is off. Deciding those answers in advance is what separates acting from debating while somebody’s breathing slows.
That conversation is hard to start, and it is harder when the person you are worried about hears it as an accusation. Family therapy is part of the program here for that reason, with a therapist in the room to keep it from turning into the argument everyone in the house has already had a dozen times. The people around the person in treatment typically carry the most and get asked about the least, and there is standing support built for them too.
The plan also has to outlast the program. The weeks right after someone finishes IOP are their own kind of exposure, because the structure that was holding a week together comes off all at once. Aftercare and steady attendance at AA or NA meetings exist to keep a person in the room past the point where a calendar says treatment ended.
Getting Back Into Treatment After a Return to Use
If a recurrence has already happened, last night or last spring, to you or to somebody whose name you have not said out loud yet, the next call does not have to be a confession. Our admissions team will ask what happened, work out which level of care fits the situation now, and tell you what your plan actually covers before anything goes on a calendar.
If today is not the day to make that call, put naloxone in the house in the meantime and come back to it when you are ready. How long it took to get here will not change how you are met. If someone is in immediate danger, call 911. The Suicide & Crisis Lifeline answers calls and texts at 988, and SAMHSA’s National Helpline, 1-800-662-4357, is a free and confidential treatment referral and information service.
Frequently Asked Questions About Overdose Awareness Day
It is common. The National Institute on Drug Abuse compares rates of return to substance use after treatment with the rates seen in chronic conditions like high blood pressure and asthma, and treats a recurrence of symptoms as a signal to resume, modify, or change treatment rather than as evidence that treatment failed. In outpatient care the exposure is deliberate, because a person is practicing new skills inside their actual week. What matters most is telling the clinical team quickly, since that is what allows the level of care, the therapy plan, or the medication to be adjusted before the situation gets more dangerous.
Tolerance, the amount of a substance the body has adjusted to handling, falls quickly once use stops. NIDA states that a person who uses as much as they did before quitting can easily overdose, because the body is no longer adapted to that level of exposure. The dose that felt ordinary a few months earlier can slow or stop breathing after a stretch of abstinence. Fentanyl in the supply narrows the margin further, since it appears in pills and powders sold as something else and small differences in a single dose can matter.
Yes. NIDA advises that families of people with opioid use disorder keep naloxone nearby, ask the person to carry it, and make sure friends know where it is. In Georgia it is sold over the counter at most major pharmacies, the state maintains a prescription standing order, and the Department of Public Health lists organizations that distribute it free. Georgia’s Medical Amnesty Law also provides limited immunity for anyone seeking medical help during an overdose and protects the possession and administration of naloxone. Always call 911, because naloxone works for only 30 to 90 minutes and many opioids last longer than that.
Sources
- National Institute on Drug Abuse. (n.d.). Treatment and recovery. Retrieved from: https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery. Accessed on August 28, 2026.
- National Institute on Drug Abuse. (n.d.). Naloxone DrugFacts. Retrieved from: https://nida.nih.gov/publications/drugfacts/naloxone. Accessed on August 28, 2026.
- National Institute on Drug Abuse. (n.d.). Fentanyl. Retrieved from: https://nida.nih.gov/research-topics/fentanyl. Accessed on August 28, 2026.
- Substance Abuse and Mental Health Services Administration. (n.d.). Treatment options for substance use disorder. Retrieved from: https://www.samhsa.gov/substance-use/treatment/options. Accessed on August 28, 2026.
- Georgia Department of Public Health. (n.d.). Naloxone. Retrieved from: https://dph.georgia.gov/stopopioidaddiction/what-you-need-know-about-opioids/naloxone. Accessed on August 28, 2026.
- Georgia Department of Behavioral Health and Developmental Disabilities. (n.d.). Help with substance abuse. Retrieved from: https://dbhdd.georgia.gov/be-supported/help-substance-abuse. Accessed on August 28, 2026.
- American Society of Addiction Medicine. (n.d.). The ASAM criteria. Retrieved from: https://www.asam.org/asam-criteria. Accessed on August 28, 2026.